Terence Friedlander, MD
2 clinical trials · Sponsor
◉ Watch Terence Friedlander, MD
| Record | Firm | Date |
|---|---|---|
| Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer (NCT03150836) | Terence Friedlander, MD | 2017-10-01 |
Track Terence Friedlander, MD automatically
Every clearance here is in the API, with alerts when new ones post.